Clinical Trial: An Open-label, Long-term Extension Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of TLL-018 in Patients With Rheumatoid Arthritis

U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT06887127) titled 'An Open-label, Long-term Extension Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of TLL-018 in Patients With Rheumatoid Arthritis' on March 14.

Brief Summary: The primary objective of the study is to evaluate the long-term safety, tolerability, and efficacy of TLL-018 in patients with rheumatoid arthritis (RA) who have completed a preceding randomized controlled trial with TLL-018.

Study Start Date: March 10

Study Type: INTERVENTIONAL

Condition: Rheumatoid Arthritis

Intervention: DRUG: TLL-018

TLL-018 20 mg BID for 78 weeks

Recruitment Status: RECRUITING

Sponsor: Hangzhou Highlightll Pharmaceutical Co.,...